KIRA-7

CAT: 0804-HY-124646-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-124646-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
KIRA-7, an imidazopyrazine compound, binds the IRE1α kinase (IC50 of 110 nM) to allosterically inhibit its RNase activity. KIRA-7 has an anti-fibrotic effect[1].
CAS Number
[1937235-76-1]
UNSPSC
12352005
Target
IRE1
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/kira-7.html
Concentration
10mM
Purity
99.09
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CC(F)=C1)NC2=C3C=CC=CC3=C(C4=C5C(N)=NC=CN5C(C6(C)CC6)=N4)C=C2
Molecular Formula
C27H23FN6O
Molecular Weight
466.51
References & Citations
[1]Thamsen M, et al. Small molecule inhibition of IRE1α kinase/RNase has anti-fibrotic effects in the lung. PLoS One. 2019 Jan 9;14 (1) :e0209824.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-164098JWZ-7-7-Neg1
HY-152793-017-Cyano-7-deazaguanosine
HY-149582Aβ-IN-7
HY-117136AN-7
HY-W001494-017-Methoxy-7-oxoheptanoic acid
HY-1321477-Deaza-7-propargylamino-ddATP
HY-1321447-Deaza-7-propargylamino-dGTP
HY-N11492-017 (R) -7,8-Dihydrosinomenine
HY-167705(R) -7,7'-Dihydrotaiwanin C
HY-W7507267,8,7’,8’-Tetradehydroastaxanthin

Alternative Products

CatalogName
BA4214-5KIRA-7
X-LCP-1057.7 MAG
sc-390856Dok-7 (A-7)
TBZ12367,7α-Diepialexine
MBS71619887.7 Antibody
sc-398919Siglec-7 (A-7)
H998456Heptanoic-7,7,7-d3 Acid
B6838921-Bromoheptane-7,7,7-d3
168296IL-7 (IL7, IL-7 Interleukin 7, Interleukin-7)
C 214-057- Cyano- 7- deazainosine (7-CN-7-C-Ino / Jaspamycin)

Popular Products